These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10789829)

  • 1. Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors.
    Shapira M; Vogel Z; Sarne Y
    Cell Mol Neurobiol; 2000 Jun; 20(3):291-304. PubMed ID: 10789829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors.
    Xu H; Wang X; Partilla JS; Bishop-Mathis K; Benaderet TS; Dersch CM; Simpson DS; Prisinzano TE; Rothman RB
    Brain Res Bull; 2008 Sep; 77(1):49-54. PubMed ID: 18639745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
    Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mu and Delta opioid receptors activate the same G proteins in human neuroblastoma SH-SY5Y cells.
    Alt A; Clark MJ; Woods JH; Traynor JR
    Br J Pharmacol; 2002 Jan; 135(1):217-25. PubMed ID: 11786497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gi/o-coupled receptors compete for signaling to adenylyl cyclase in SH-SY5Y cells and reduce opioid-mediated cAMP overshoot.
    Levitt ES; Purington LC; Traynor JR
    Mol Pharmacol; 2011 Mar; 79(3):461-71. PubMed ID: 21098043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [35S]-GTP-gamma-S binding at cloned opioid receptors.
    Xu H; Lu YF; Rice KC; Ananthan S; Rothman RB
    Brain Res Bull; 2001 Jul; 55(4):507-11. PubMed ID: 11543951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Region-dependent G-protein activation by mu-, delta 1- and delta 2-opioid receptor agonists in the brain: comparison between the midbrain and forebrain.
    Tsuji M; Narita M; Mizoguchi H; Narita M; Ohsawa M; Kamei J; Nagase H; Takeda H; Matsumiya T; Tseng LF
    Life Sci; 1999; 65(16):PL233-9. PubMed ID: 10573190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independence of, and interactions between, cannabinoid and opioid signal transduction pathways in N18TG2 cells.
    Shapira M; Gafni M; Sarne Y
    Brain Res; 1998 Sep; 806(1):26-35. PubMed ID: 9739102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of extracellular signal-regulated kinase (ERK) by opioid and cannabinoid receptors that are expressed in the same cell.
    Korzh A; Keren O; Gafni M; Bar-Josef H; Sarne Y
    Brain Res; 2008 Jan; 1189():23-32. PubMed ID: 18068691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoradiographic distribution of mu-, delta- and kappa 1-opioid stimulated [35S]guanylyl-5'-O-(gamma-thio)-triphosphate binding in human frontal cortex and cerebellum.
    Platzer S; Winkler A; Schadrack J; Dworzak D; Tölle TR; Zieglgänsberger W; Spanagel R
    Neurosci Lett; 2000 Apr; 283(3):213-6. PubMed ID: 10754225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mu and delta opioids but not kappa opioid inhibit voltage-activated Ba2+ currents in neuronal F-11 cell.
    Nah SY; Unteutsch A; Bunzow JR; Cook SP; Beacham DW; Grandy DK
    Brain Res; 1997 Aug; 766(1-2):66-71. PubMed ID: 9359588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and chronic effects of opioids on delta and mu receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes.
    Breivogel CS; Selley DE; Childers SR
    J Neurochem; 1997 Apr; 68(4):1462-72. PubMed ID: 9084416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of phospholipase C by the cloned mu, delta and kappa opioid receptors via chimeric G alpha(q) mutants.
    Joshi S; Lee JW; Wong YH
    Eur J Neurosci; 1999 Feb; 11(2):383-8. PubMed ID: 10051738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of G-protein activation in the brain by mu-, delta-, and kappa-opioid receptor agonists in mu-opioid receptor knockout mice.
    Park Y; Ma T; Tanaka S; Jang C; Loh HH; Ko KH; Ho IK
    Brain Res Bull; 2000 Jul; 52(4):297-302. PubMed ID: 10856828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen.
    Corchero J; Romero J; Berrendero F; Fernandez-Ruiz J; Ramos JA; Fuentes JA; Manzanares J
    Brain Res Mol Brain Res; 1999 Apr; 67(1):148-57. PubMed ID: 10101241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term interactions between opioid and cannabinoid agonists at the cellular level: cross-desensitization and downregulation.
    Shapira M; Gafni M; Sarne Y
    Brain Res; 2003 Jan; 960(1-2):190-200. PubMed ID: 12505672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
    Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
    Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard opioid agonists activate heteromeric opioid receptors: evidence for morphine and [d-Ala(2)-MePhe(4)-Glyol(5)]enkephalin as selective μ-δ agonists.
    Yekkirala AS; Kalyuzhny AE; Portoghese PS
    ACS Chem Neurosci; 2010 Feb; 1(2):146-54. PubMed ID: 22816017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor.
    Matthes HW; Smadja C; Valverde O; Vonesch JL; Foutz AS; Boudinot E; Denavit-Saubié M; Severini C; Negri L; Roques BP; Maldonado R; Kieffer BL
    J Neurosci; 1998 Sep; 18(18):7285-95. PubMed ID: 9736649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.